Source: Annual Congress 2001 - Effects of a changing environment on the lungs
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Vagaggini, M. Taccola, S. Carnevali, S. Cianchetti, M. L. Bartoli, E. Bacci, F. L. Dente, A. Di Franco, D. Giannini, E. Masino, P. L. Paggiaro (Pisa, Italy). Inflammatory airway response to 0.26 PPM of ozone in asthmatic subjects with or without airway obstruction. Eur Respir J 2001; 16: Suppl. 31, 1336

Member's Comments

No comment yet.

Related content which might interest you: Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006 Airway inflammation and upper airway infection in asthmatic children Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Airway inflammation in symptomatic and asymptomatic subjects with and without airway hyperresponsiveness Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001 Increased airway closure is a determinant of airway hyperresponsiveness Source: Eur Respir J 2008; 32: 1563-1569 Year: 2008 Relationship between peripheral airway obstruction and airway inflammation in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 509s Year: 2006 Airway inflammation and airway pathophysiology in older asthmatics Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Airway resistance at maximum inhalation as a marker of asthma and airway hyperresponsiveness in children Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Airway inflammation and airway dynamics during deep inspiration in asthma and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 831s Year: 2006 Markers of inflammation and airway responses to allergen in asthmatic patients Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008 Markers of airway inflammation and airway hyperresponsiveness remain stable in untreated asthmatics over time Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Bronchial reversibility and airway inflammation in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006 Airway inflammation affects the perception of bronchoconstriction in asthma but not in CAO patients Source: Eur Respir J 2003; 22: Suppl. 45, 417s Year: 2003 Bronchial hyperreactivity and airway inflammatory markers in nonasthmatic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 476s Year: 2003 Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Airway remodeling in severe asthmatics with fixed or variable airflow obstruction Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma Year: 2007 Spontaneous airway obstruction masks FeNO level in patients with asthma but not COPD Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Exhaled NO, small airway obstruction and airway hyper-responsiveness in pediatric asthma Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 Sputum eosinophilia, airway hyperresponsiveness and airway narrowing in young adults with former asthma Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005